Bayforest Capital LTD Rhythm Pharmaceuticals, Inc. Transaction History
Bayforest Capital LTD
- $121 Billion
- Q1 2025
A detailed history of Bayforest Capital LTD transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Bayforest Capital LTD holds 3,134 shares of RYTM stock, worth $204,399. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,134Holding current value
$204,399% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
224Shares Held
64.9MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$440 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$397 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$397 Million3.77% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$377 Million0.26% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$240 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.63B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...